NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cyted Health

Cyted Health

Private
CambridgeHealthcare & Life Scienceshttps://www.cytedhealth.com/

Last Round

Series B

Aug 30, 2025

Total Funding Raised

$70.54M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cyted Health is a life sciences company that provides a non-endoscopic diagnostic platform and artificial intelligence-driven pathology services for the early detection of gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

esophageal cancer screeningcytospongedigital pathologynon-invasive diagnosticscomputational pathologyBarrett's esophagusAI diagnosticsmedical devicediagnostic laboratorypathology triageliquid biopsyhealthcare analyticsgastroenterologysmart pillclinical pathway

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cyted Health Comparables

Compare Cyted Health with similar companies based on industry and business-model similarity.

Cyted Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PAVmed Inc.
78%
CDx Diagnostics
65%
Medtronic
61%

Cyted Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 30, 2025
GrantFeb 19, 2025
VC RoundMay 17, 2023
Series AMay 17, 2023
SeedFeb 1, 2020
VC Round
Feb 1, 2020

Key People

Founding team and executive leadership

Marcel Gehrung

CEO & Founder

Founding Team

Neha Goel

Chief Operating Officer

Executive Team

Cyted Health Investors

Notable investors and investment history

Cyted Health investors
InvestorRounds
Innovate UKSeed
EQT Life SciencesSeries B
SBRI HealthcareVC Round
BGFSeries B, VC Round, Series A
SBRI Centre of ExcellenceGrant
British Business BankSeries B
Morningside VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    US molecular diagnostic test in final validation and early commercialization.

  • Apr 25, 2026

    Diagnostic solutions integrated into NHS pathways across UK sites.

Cyted Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cyted Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cyted Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range73
Year Founded2018
Last FundingAug 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.